genXone S.A. (WSE:GX1)

Poland flag Poland · Delayed Price · Currency is PLN
5.92
-0.48 (-7.50%)
At close: Mar 9, 2026
4.96%
Market Cap 19.76M
Revenue (ttm) 2.34M
Net Income (ttm) -2.14M
Shares Out 3.30M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,178
Average Volume 3,642
Open 5.80
Previous Close 6.40
Day's Range 5.42 - 6.00
52-Week Range 3.81 - 6.48
Beta -0.24
RSI 61.92
Earnings Date Feb 10, 2026

About genXone

genXone S.A. operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally. The company operates in the field of molecular genetics and bioinformatics. It also develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture. genXone S.A. was incor... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2018
Employees 17
Stock Exchange Warsaw Stock Exchange
Ticker Symbol GX1
Full Company Profile

Financial Performance

In 2025, genXone's revenue was 2.34 million, an increase of 31.07% compared to the previous year's 1.79 million. Losses were -2.14 million, -45.39% less than in 2024.

Financial Statements

News

There is no news available yet.